Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about the response of Langerhans cell histiocytosis
(LCH) to Enbrel in patients who have failed to respond to standard therapies. We are also
looking specifically at what side effects Enbrel has on patients. We expect to enroll 20
patients on this study and anticipate the subjects active participation to last up to one
year.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Texas Children's Hospital The Methodist Hospital Research Institute The Methodist Hospital System